dGen

Sparking Interest, Blockchain & Fellowship Programme With Carlos Gómez As part of our goal of curating research that matters to innovators at the forefront of emerging technology, we’ve created a community of experts to weigh-in on our reports. These Fellows collaborate throughout our research process and provide us with invaluable insights and quotes. As the network has grown, we want to take some time to highlight the individuals who make up this community. Carlos Gómez is…
What will the fallout of China’s CBDC be on the Euro? The global power that controlling world trade brings means that countries have been vying for this position since the 1400s. While never out of the minds of world leaders, this struggle for dominance continues to make news and is increasingly tied to emerging tech circles. Central Bank Digital Currencies or CBDCs have been the cause of this. This is increased by China preparing to launch its…
Finance, Startups, and Driving Innovation with Dr. Estelle Brack Dr. Estelle Brack, Founder & Chairman of KiraliT, is at the forefront of digitisation in the financial sector. She recently joined dGen as the Fellow of France. In this capacity, she will serve as an expert advisor on our research, and help us develop the most interesting areas of research. We reached out to get a few more insights into what she’s working on, the…
August 2020 In August, while many people take holidays and time to disconnect, the research agenda doesn’t stop. Despite the heat, white papers, work papers, and research reports have continued rolling. In the tech ecosystem, high-quality content abounds. There is always research that you don’t want to miss, and our team has picked the best releases of August. Here we’ve compiled our top recommendations: 1. Bank of International Settlements Rise of the central bank digital currencies:
with Tikshala Gothankar It has been three months since our Ambassador Programme kicked off. Tikshala Gothankar, our dGen Ambassador for The Netherlands, was the first person who joined this programme. Since then, she has never stopped to surprise us with her outstanding performances and a hard-working mindset. Her passion for technology, her desire to learn from the European tech ecosystem, and her determination make her a priceless asset within the dGen Team. She shared with us…
Nowadays, Artificial Intelligence (AI) is much-discussed and attracts the interest of many people from different fields. Its developments are exciting and rapid, as can be seen by the new Wunderkind on the block, GPT-3. Its technologies are being applied in an increasing number of industries. Despite this, it’s often not understood what AI is. To shed some light on the topic, we will explain what AI is and the different useful types for the healthcare field.…
Define the Future of Tech in Europe It has been over a year since we began the adventure of educating people, organisations and governments with monthly research reports. Our mission is to speak to the general public about Artificial Intelligence, blockchain, and IoT in language anybody can understand. We believe that while these emerging technologies are individually bringing disruptive innovation, their convergence is where the greatest innovation and people-first technologies lie. The pandemic forced the world…
With David Vatchev of R3 David Vatchev, Venture Development Lead at R3, shared with us some predictions for R3 and the Corda Venture Development Ecosystem. Delving into R3’s stance on DeFi and OpenFI, he outlined the biggest challenges blockchain start-ups are currently facing and the future potential opportunities in the sector. Hi, David. Thank you so much for taking the time to talk to us. First off, could you tell us a bit about who R3 is?…
The start of the new decade came with the global spread of a novel coronavirus; a global pandemic defining developments in economics, international politics, and disrupting the day-to-day life of society at large. As experts and authorities rely on the development of a vaccine to overcome COVID-19, the world turns to the pharmaceutical industry, medical research, and technology with much anticipation. Can artificial intelligence offer a solution, and if so, what are the consequences for…